glutamine has been researched along with Nervous System Disorders in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (33.33) | 18.7374 |
1990's | 9 (33.33) | 18.2507 |
2000's | 6 (22.22) | 29.6817 |
2010's | 2 (7.41) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Holeček, M | 1 |
Jayakumar, AR; Norenberg, MD | 1 |
Campagna, G; Grilli, A; La Fratta, I; Pesce, M; Rizzuto, A; Tatangelo, R | 1 |
HARRIS, MM; HARRIS, RS; ROTH, RT | 1 |
BOLDT, F | 1 |
Alonso, J; Córdoba, J; Esteban, R; Guardia, J; Jacas, C; Ortiz, M; Quiroga, S; Rovira, A | 1 |
Chen, PM; Chen, WS; Chiou, TJ; Jiang, JK; Lin, JK; Lin, TC; Liu, JH; Wang, HS; Wang, WS; Yen, CC | 1 |
Prusiner, SB | 1 |
Ross, CA | 1 |
Blackburn, JM; Butler, PJ; Perutz, M; Stott, K | 1 |
Kazemi-Esfarjani, P; Pinsky, L; Trifiro, MA | 1 |
Perutz, M | 1 |
Djian, P; Green, H; Kahlem, P; Terré, C | 1 |
Perutz, MF | 1 |
Alford, RL; Margolis, RL; Richards, CS; Ross, CA | 1 |
Deng, HX; Fan, CH; Hung, WY; Siddque, T; Xia, JH; Xu, L; Yang, Y | 1 |
Obrenovitch, TP | 1 |
Aguiar, J | 1 |
Danbolt, NC | 1 |
Baker, SD; Bowling, MK; Carducci, MA; Donehower, RC; Figg, WD; Gilbert, J; Grochow, L; Zabelina, Y | 1 |
Garlick, PJ | 1 |
Montini, M; Ongaro, A; Simonutti, M | 1 |
Hussain, MM; Plaitakis, A; Zannis, VI | 1 |
Hattori, M; Hiraoka, A; Miura, I; Tominaga, I | 1 |
Hambraeus, L; Ulwán, O | 1 |
Braksh, TA | 1 |
Brink, P; Harum, A; Zacarias, J | 1 |
11 review(s) available for glutamine and Nervous System Disorders
Article | Year |
---|---|
Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement.
Topics: Amino Acids, Branched-Chain; Ammonia; Chelating Agents; Contraindications; Dermatitis, Atopic; Dietary Supplements; Filaggrin Proteins; Free Radical Scavengers; Glutamine; Histamine; Histidine; Humans; Hypertrophy; Liver; Liver Diseases; Metabolic Syndrome; Nervous System Diseases; Organ Preservation Solutions | 2020 |
Glutamine Synthetase: Role in Neurological Disorders.
Topics: Ammonia; Astrocytes; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Humans; Nervous System Diseases | 2016 |
The progression of coeliac disease: its neurological and psychiatric implications.
Topics: Adult; Celiac Disease; Cognitive Dysfunction; Diet, Gluten-Free; Disease Progression; Edible Grain; Environment; Female; Genetic Predisposition to Disease; Glutamine; Humans; Immune System Diseases; Immunity; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Plant Proteins; Proline | 2017 |
Disorders of glutamate metabolism and neurological dysfunction.
Topics: Amino Acid Metabolism, Inborn Errors; Ammonia; Animals; gamma-Aminobutyric Acid; Glutamates; Glutamine; Glutathione; Histidine; Humans; Ketoglutaric Acids; Nervous System Diseases; Proline; Pyrrolidonecarboxylic Acid | 1981 |
When more is less: pathogenesis of glutamine repeat neurodegenerative diseases.
Topics: Animals; Cell Death; Glutamine; Humans; Mutation; Nerve Tissue Proteins; Nervous System Diseases; Neurons; Repetitive Sequences, Nucleic Acid | 1995 |
Polar zippers: their role in human disease.
Topics: Amino Acid Sequence; Animals; Ascaris; Genetic Diseases, Inborn; Glutamine; Hemoglobins; Humans; Lupus Erythematosus, Systemic; Molecular Sequence Data; Nervous System Diseases; Repetitive Sequences, Nucleic Acid; Ribonucleoproteins, Small Nuclear | 1994 |
Glutamine repeats and inherited neurodegenerative diseases: molecular aspects.
Topics: Genetic Diseases, Inborn; Glutamine; Models, Molecular; Mutation; Nervous System Diseases; Nucleic Acid Conformation; Protein Structure, Secondary; Recombination, Genetic; Repetitive Sequences, Nucleic Acid | 1996 |
High extracellular glutamate and neuronal death in neurological disorders. Cause, contribution or consequence?
Topics: 4-Aminopyridine; Animals; Calcium; Cell Death; Cortical Spreading Depression; Excitatory Amino Acid Antagonists; Exocytosis; Glutamic Acid; Glutamine; Nervous System Diseases; Neurons; Potassium; Potassium Channel Blockers; Presynaptic Terminals; Rats; Sodium Channel Blockers; Tetrodotoxin | 1999 |
Glutamate uptake.
Topics: Amino Acid Transport System X-AG; Anesthetics; Animals; ATP-Binding Cassette Transporters; Bone and Bones; Brain; Carrier Proteins; Ethanol; Extracellular Space; Female; Gene Expression Regulation; Glutamic Acid; Glutamine; Hepatic Encephalopathy; HIV Infections; Humans; Intracellular Fluid; Ion Channel Gating; Ion Channels; Ion Transport; Ischemia; Male; Mammals; Mercury Poisoning; Monocarboxylic Acid Transporters; Nerve Tissue Proteins; Nervous System Diseases; Neuroglia; Neurons; Neurotransmitter Agents; Organ Specificity; Placenta; Potassium; Pregnancy; Protein Conformation; Rats; Receptors, Glutamate; Sodium; Synapses; Synaptic Transmission; Viscera | 2001 |
Assessment of the safety of glutamine and other amino acids.
Topics: Administration, Oral; Adult; Age Factors; Amino Acids; Animals; Clinical Trials as Topic; Dietary Proteins; Dietary Supplements; Dose-Response Relationship, Drug; Glutamine; Humans; Infant; Infusions, Intravenous; Nausea; Nervous System Diseases; Nutrition Policy; Parenteral Nutrition, Total; Quality Control; Time Factors | 2001 |
[Role of some amine acids in clinical proctice (literature review)].
Topics: Amino Acids; Animals; Glutamine; Humans; Myocardium; Nervous System; Nervous System Diseases | 1969 |
3 trial(s) available for glutamine and Nervous System Disorders
Article | Year |
---|---|
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorouracil; Glutamine; Humans; Leucovorin; Male; Middle Aged; Nervous System Diseases; Neuroprotective Agents; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Treatment Outcome | 2007 |
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.
Topics: Administration, Oral; Adult; Aged; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Edema; Fatigue; Female; Glutamine; Humans; Hypocalcemia; Male; Middle Aged; Nausea; Neoplasms; Nervous System Diseases; Phenylacetates; Phenylbutyrates; Treatment Outcome; Vomiting | 2001 |
[Controlled clinical study and clinico-psychological evaluation of a preparation with neurotrophic effects].
Topics: Aged; Arginine; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Glutamine; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Organophosphorus Compounds; Serine; Threonine; Tryptophan; Vitamin B 12 | 1977 |
13 other study(ies) available for glutamine and Nervous System Disorders
Article | Year |
---|---|
Studies regarding glutamine and ammonia in the cerebrospinal fluid of patients with nervous and mental diseases (with some observations on insulin hypoglycemic shock and oligophrenia phenylpyruvica).
Topics: Ammonia; Cerebrospinal Fluid; Glutamine; Humans; Hypoglycemic Agents; Insulin; Intellectual Disability; Mental Disorders; Nervous System Diseases; Neurotic Disorders; Phenylketonurias; Psychopathology; Psychotic Disorders | 1945 |
[Effects of glutamine in organic nervous diseases].
Topics: Anxiety; Central Nervous System Diseases; Glutamates; Glutamine; Nervous System Diseases | 1952 |
Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts.
Topics: Administration, Oral; Adult; Ammonia; Area Under Curve; Brain; Cardiovascular Abnormalities; Female; Glutamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nervous System Diseases; Neuropsychological Tests; Portal System; Tomography, Spiral Computed | 2004 |
Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.
Topics: Amino Acid Sequence; Base Sequence; Circular Dichroism; DNA Primers; Glutamine; Humans; Hydrogen Bonding; Macromolecular Substances; Male; Models, Structural; Molecular Sequence Data; Mutagenesis, Insertional; Nervous System Diseases; Oligodeoxyribonucleotides; Peptides; Protein Structure, Secondary; Recombinant Proteins; Repetitive Sequences, Nucleic Acid; Spectrophotometry, Ultraviolet | 1995 |
Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies.
Topics: Base Sequence; Cell Line; DNA Primers; Electroporation; Glutamine; Humans; Molecular Sequence Data; Nervous System Diseases; Polyribonucleotides; Receptors, Androgen; Transcriptional Activation | 1995 |
Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
Topics: Amino Acid Sequence; Binding Sites; Cross-Linking Reagents; Glutamine; Humans; Molecular Sequence Data; Nervous System Diseases; Peptides; Repetitive Sequences, Nucleic Acid; Substrate Specificity; Transglutaminases | 1996 |
Southern analysis for detection of CAG repeat expansions associated with dentatorubral pallidoluysian atrophy.
Topics: Atrophy; Blotting, Southern; Brain; Glutamine; Humans; Nervous System Diseases; Trinucleotide Repeats | 1997 |
Assignment of SATB1 to human chromosome band 3p23 by in situ hybridization.
Topics: Chromosome Mapping; Chromosomes, Human, Pair 3; DNA Probes; DNA-Binding Proteins; Glutamine; Humans; In Situ Hybridization, Fluorescence; Matrix Attachment Region Binding Proteins; Molecular Sequence Data; Nervous System Diseases; Repetitive Sequences, Nucleic Acid | 1997 |
Identification of six CAG repeat domains into the human chromosomic region 12q24.1.
Topics: Anticipation, Genetic; Ataxins; Base Sequence; Chromosome Walking; Chromosomes, Artificial, Yeast; Chromosomes, Human, Pair 12; Cloning, Molecular; Codon; Cosmids; DNA Probes; Genetic Linkage; Glutamine; Histidine; Human Genome Project; Humans; Molecular Sequence Data; Nerve Tissue Proteins; Nervous System Diseases; Peptides; Proteins; Trinucleotide Repeat Expansion; Trinucleotide Repeats | 2000 |
Characterization of glutamate dehydrogenase isoproteins purified from the cerebellum of normal subjects and patients with degenerative neurological disorders, and from human neoplastic cell lines.
Topics: Adolescent; Adult; Aged; Amino Acids; Carcinoma, Hepatocellular; Cell Line; Cerebellar Cortex; Cerebellum; Child; Glioma; Glutamate Dehydrogenase; Glutamine; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Male; Middle Aged; Nervous System Diseases; Neurotransmitter Agents; Reference Values; Tumor Cells, Cultured | 1989 |
Capillary-isotachophoretic determination of glutamine in cerebrospinal fluid of various neurological disorders.
Topics: Brain Diseases; Electrophoresis; Glutamine; Humans; Nervous System Diseases | 1989 |
[The amino-acid pattern of cerebrospinal fluid in normal and pathological conditions].
Topics: Amino Acids; Anencephaly; Child; Female; Glutamates; Glutamine; History, 20th Century; Humans; Hydrocephalus; Infant; Nervous System Diseases | 1968 |
[Glutamine levels of the cerebrospinal fluid. Study of 101 children].
Topics: Child, Preschool; Glutamine; Humans; Infant; Liver Diseases; Nervous System Diseases | 1970 |